Similar Papers

Paper Title
Journal
Date
Author
Immunosuppression overcomes insulin- and vector-specific immune responses that limit efficacy of AAV2/8-mediated insulin gene therapy in NOD mice
Asha Recino ... Amit Nathwani
Gene Therapy | VOL. 26
Asha Recino, et. al.Asha Recino ... Amit Nathwani
04 Dec 2018
British Society for Gene and Cell Therapy Annual Conference Glasgow9–11th June 2015Conference Abstracts
-
Human Gene Therapy | VOL. 26
--
01 Sep 2015
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy.
Luigi Naldini ... Maria Pia Cicalese
HemaSphere | VOL. 6
Luigi Naldini, et. al.Luigi Naldini ... Maria Pia Cicalese
01 Feb 2022
The FDA's Regulatory Framework for Chimeric Antigen Receptor-TCell Therapies.
Peter Marks
Clinical and translational science | VOL. 12
Peter MarksPeter Marks
22 Jul 2019
View more papers

More From: Human Gene Therapy

Paper Title
Journal
Date
Author
Thrombotic Microangiopathy Associated with Systemic Adeno-Associated Virus Gene Transfer: Review of Reported Cases.
Genevieve A Laforet
Human gene therapy | VOL. -
Genevieve A LaforetGenevieve A Laforet
16 Jan 2025
Novel Cystic Fibrosis Ferret Model Enables Visualization of CFTR Expression Cells and Genetic CFTR Reactivation.
Feng Yuan ... Ziying Yan
Human gene therapy | VOL. -
Feng Yuan, et. al.Feng Yuan ... Ziying Yan
10 Jan 2025
Production of Recombinant Adeno-Associated Virus Through High-Cell-Density Transfection of HEK293 Cells Based on Fed-Perfusion Culture
Zhe Deng ... Xiao Xiao
Human Gene Therapy | VOL. -
Zhe Deng, et. al.Zhe Deng ... Xiao Xiao
06 Jan 2025
ESGCT Abstract Author Index
-
Human Gene Therapy | VOL. -
--
06 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.